Skip to main content

Craft cannabis brand house Pasha Brands Ltd. took a nosedive on its first day of trading Monday, ending the session at $0.77 per share, down from a high of $1.05.

The company, which was put together by AbCann (Vivo) and Doja (Hiku) financier Patrick Brauckmann, began trading on the Canadian Securities Exchange following the reverse takeover of a shell called Broome Capital Inc.

Pasha owns a late-stage LP (licensed producer) applicant, formerly called Royal Green Acres Management Ltd., in Nanaimo B.C., along with an intellectual property portfolio acquired from B.C.’s illicit market. That IP includes the brands Beard Brothers, Theraveda, Aurion Industries, Grizzlers and Baked Edibles. In April, the company signed a letter of intent to acquire the LP Medcann Health Products Ltd. in Chemainus, on Vancouver Island.

Story continues below advertisement

The company's business model, through subsidiary B.C. Craft Supply, revolves around sourcing cannabis from B.C. micro cultivators, processing and packaging the product in its Vancouver Island facilities, and selling it under the grey market brand names it owns. According to Mr. Brauckmann, the company has signed agreements with several dozen micro-cultivators.

Alongside Mr. Brauckmann, the board includes several cannabis industry staples, including Auxly Group’s Hugo Alves, Rosy Mondin of Quadron Cannatech and Scott Walters of Supreme.

Mr. Brauckmann is CEO while Theo van der Linde, a junior mining financier, is CFO. Eugene Beukman, another junior mining financier prominent in the cannabis space, is listed as the company’s contact for its SEDAR filings.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies